Plerixafor Solution
Product Images NDC 71288-155

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Plerixafor (NDC 71288-155). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Meitheal Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel – Plerixafor Injection 24 mg Per 1.2 mL Carton (Plerixafor Carton V3)

FDA Label Image

Structure (Plerixafor Struct)

FDA Label Image

Principal Display Panel – Plerixafor Injection 24 mg Per 1.2 mL Vial Label (Plerixafor Vial V3)

This text is a description of a medication called Plerixafor. It is an injection available in a single-dose vial with a strength of 24mg, which contains 20mg per milliliter. The medication is intended for subcutaneous injection only. The unused portion of the medication should be discarded. It is manufactured by Itheal Pharmaceuticals and is permitted to be stored at a temperature range of 15°C to 30°C (59°F to 86°F), with excursions allowed up to 25°C (77°F). The medication is preservative-free. The lot number and expiration date are not available in the provided text.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.